These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac allograft vasculopathy: pathology, prevention and treatment. Kass M; Haddad H Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150 [TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
12. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation. El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750 [TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft vasculopathy: current knowledge and future direction. Colvin-Adams M; Agnihotri A Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328 [TBL] [Abstract][Full Text] [Related]
14. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794 [TBL] [Abstract][Full Text] [Related]
15. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]